Jeffrey Hubbell to Antigen Presentation
This is a "connection" page, showing publications Jeffrey Hubbell has written about Antigen Presentation.
Connection Strength
1.367
-
Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction. Sci Immunol. 2021 02 26; 6(56).
Score: 0.690
-
Soluble N-Acetylgalactosamine-Modified Antigens Enhance Hepatocyte-Dependent Antigen Cross-Presentation and Result in Antigen-Specific CD8+ T Cell Tolerance Development. Front Immunol. 2021; 12:555095.
Score: 0.173
-
Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes. Nat Biomed Eng. 2019 10; 3(10):817-829.
Score: 0.155
-
Engineering antigen-specific immunological tolerance. Curr Opin Immunol. 2015 Aug; 35:80-8.
Score: 0.117
-
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation. Vaccine. 2010 Nov 23; 28(50):7897-906.
Score: 0.084
-
Materials engineering for immunomodulation. Nature. 2009 Nov 26; 462(7272):449-60.
Score: 0.079
-
Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design. Semin Immunol. 2008 Apr; 20(2):147-56.
Score: 0.070